Biofrontera Inc. logo

Biofrontera Inc. (BFRI) Q2 2024 Earnings

BFRI·Reported August 14, 2024·After market close

Biofrontera Inc. reported Q2 2024 revenue of $7.8M, missed analyst consensus of $8.2M by $371.0K. Diluted EPS came in at $-1.12, beat the $-1.19 consensus by $0.07.

Revenue
$7.8Mmissed by $371.0K
Consensus: $8.2M
Diluted EPS
$-1.12beat by $0.07
Consensus: $-1.19
SEC

SEC Filings

Earnings release8-K not filed yet

Financial Snapshot

Trailing eight quarters through Q2 2024

Net Income

View metric

Operating Cash Flow

View metric

EPS (Diluted)

View metric

Q2 2024 Earnings FAQ

Common questions about Biofrontera Inc.'s Q2 2024 earnings report.

Biofrontera Inc. (BFRI) reported Q2 2024 earnings on August 14, 2024 after market close.

Biofrontera Inc. reported revenue of $7.8M and diluted EPS of $-1.12 for Q2 2024.

Revenue missed the consensus estimate of $8.2M by $371.0K. EPS beat the consensus estimate of $-1.19 by $0.07.

You can read the 10-Q periodic report (0001493152-24-032216) directly on SEC EDGAR. The filing index links above go to sec.gov.